Flora Growth Corp

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis, Over-the-Counter Medical Products and Medical Cannabis Products, Wellbeing Products, and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Fort Lauderdale, Florida--(Newsfile Corp. - September 19, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the integration of Sezzle, a leading "buy now, pay later" (BNPL) platform into its U.S. e-commerce platforms for JustCBD and Vessel. This payment option allows consumers to finance their purchases, making Flora's products more accessible to a broader audience.

Flora Growth Corp. Integrates Sezzle Financing Option for JustCBD and Vessel Purchases Across U.S. E-Commerce Platforms

Fort Lauderdale, Florida--(Newsfile Corp. - September 18, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce a strategic supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market. This partnership will introduce two high sought-after exotic strains, Chemmy Jones and Northern Lights, to Germany, supporting Flora's mission to meet the country's growing demand for high-quality medical cannabis following the legalization of cannabis on April 1, 2024.

Flora Growth Corp. Announces Supply Agreement with Blossom Genetics to Bring Colombian Medical Cannabis to Germany

Fort Lauderdale, Florida--(Newsfile Corp. - September 17, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Clifford Starke, Chief Executive Officer, to the Board of Directors of HoshiCap, a subsidiary of Hoshi International ("Hoshi") which has a cannabis-cultivation facility in Portugal. Flora initially made an equity investment of $2.4 million into Hoshi in 2021, securing a 10% ownership in the company.

Clifford Starke, CEO of Flora Growth Corp., Appointed to HoshiCap Board of Directors

Panama City, Panama--(Newsfile Corp. - September 12, 2024) - On August 14, 2024, at the annual meeting of the shareholders of Flora Growth Corp. (the "Issuer"), the shareholders of the Issuer approved: (a) the December 15, 2023, issuance of 1,028,665 stock appreciation rights ("SARs") to Clifford Starke (the "Acquiror") and the; (b) the August 14, 2024 issuance of 575,319 SARs to the Acquiror. The SARs vest in 12 equal installments, subject to Issuer share price criteria, have a ten-year term, and a post-termination exercise price of one year (the "Acquisition").

Clifford Starke's Holdings in Flora Growth Corp.

Femto Technologies Inc.

Fort Lauderdale, Florida--(Newsfile Corp. - September 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Harold Wolkin as an independent director on its Board of Directors. In this role, Mr.

Flora Growth Corp. Appoints Harold Wolkin to Board of Directors; Clifford Starke Named Chairman

Fort Lauderdale, Florida--(Newsfile Corp. - September 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of its new corporate branding, logo, website, marking an exciting step forward in the company's continued evolution and growth. The new branding initiative reflects the Company's commitment to innovation and its dedication to providing high-quality, premium products.

Flora Growth Corp. Unveils New Branding, Logo, Website in Exciting Design Transformation

Fort Lauderdale, Florida--(Newsfile Corp. - August 14, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") held its 2024 Annual and Special Meeting of Shareholders (the "Annual Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: Election of four directors to the Board of Directors of the Company (the "Board") to hold office until the Company's 2025 Annual Meeting of Shareholders or until their respective successors are elected or appointed:   Broker Director For Against   Abstentions Non-Votes Clifford Starke 4,969,741 97,612   18,969 2,778,760 Kevin Taylor 4,931,118 129,648   25,556 2,778,760 Edward Woo 4,881,581 179,654   25,087 2,778,760 Brendan Cahill 5,001,476 57,680   27,166 2,778,760   Proposal 2: Reappointment of Davidson & Company LLP, an independent registered public accounting firm, as auditors of the Company for the fiscal year ending December 31, 2024 and authorization of the Board to fix their renumeration.

Flora Growth Announces Results of 2024 Annual and Special Meeting of Shareholders

Fort Lauderdale, Florida--(Newsfile Corp. - August 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") reported today its financial and operating results for the three and six months ended June 30, 2024. "In the second quarter of 2024, we at Flora, demonstrated an aptitude to make accretive acquisitions and form strategic partnerships to capitalize on the most robust market trends.

Flora Growth Corp. Reports Second Quarter 2024 Financial Results

Fort Lauderdale, Florida--(Newsfile Corp. - August 8, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") proudly celebrates National CBD Day, a day dedicated to recognizing the vast benefits and rapid growth of the CBD industry in the United States and beyond. National CBD Day not only celebrates the therapeutic benefits of cannabidiol ("CBD") but also serves as a reminder of the political strides made in recent years.

Flora Growth Celebrates National CBD Day

Fort Lauderdale, Florida--(Newsfile Corp. - August 7, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce that the Company's common shares now trade on the Frankfurt Stock Exchange ("FSE") under the symbol "7301". The Frankfurt Stock Exchange is one of the world's largest (behind only the Nasdaq and NYSE) organized exchange-trading market in terms of turnover and dealings with securities.

Flora Growth Announces Frankfurt Stock Exchange Listing

Fort Lauderdale, Florida--(Newsfile Corp. - August 6, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company")'s JustCBD, a leading consumer products brand, is excited to introduce two new products to its line of offerings - JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies and JustCBD+ Sleep Magnesium and Melatonin Raspberry Gummies. These innovative gummies are designed to support stress management and promote relaxation, as well as enhance sleep quality.

Flora Growth Announces Launch of New Calm and Sleep Gummies

Fort Lauderdale, Florida--(Newsfile Corp. - June 5, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company") has entered into a share purchase agreement (the "Agreement") to acquire of all of the issued and outstanding shares of Australian Vaporizers Pty Limited ("Australian Vaporizers") in exchange for 550,000 Flora common shares, valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The transaction closed on June 4, 2024.

Flora Growth Corp. Closes Acquisition of Australian Vaporizers

Flora and Althea have established Peak USA JV LLC ("Peak USA") - a 50/50 joint venture aiming to capitalize on the beverages market. Each party to the joint venture contributed $250,000 of operating capital.

Flora Growth Corp. Forms Joint Venture with Althea Group Holdings to Create Leading Beverages Brand in U.S. Market

Fort Lauderdale, Florida--(Newsfile Corp. - May 30, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company")'s Vessel Brand ("Vessel"), renowned for its design and precision craftsmanship, proudly announces the release of Compass Rise. Built for the discerning connoisseur, Compass Rise embodies sophistication while delivering what consumers have come to expect from Vessel's products.

Vessel Brand Unveils the Second-Generation Compass Rise - The Next Evolution in Functionality and Elegance

EVgo

Zura Bio Ltd

Penny stocks to buy carry a considerable amount of risk. That's why we include the disclaimer at the tail-end of this article.

3 Penny Stocks to Buy Now: May 2024

Fort Lauderdale, Florida--(Newsfile Corp. - May 16, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor, is pleased to announce that it has joined the Hemp Beverage Alliance. "At this moment, beverages represent only a marginal component of the industry.

Flora Growth Corp. Joins U.S. Hemp Beverage Alliance

Fort Lauderdale, Florida--(Newsfile Corp. - May 14, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor, reported today its financial and operating results for the three months ended March 31, 2024. "2024 has been a catalyst-rich period for Flora.

Flora Growth Corp. Reports First Quarter 2024 Financial Results

Aurora Cannabis

Canopy Growth

For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.

Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks

Fort Lauderdale, Florida--(Newsfile Corp. - May 1, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor, is applauding the reported historic move by the U.S. Drug Enforcement Administration ("DEA") to reclassify cannabis from its list of Schedule I drugs to Schedule III, following a recommendation from the federal Health and Human Services Department ("HHS"). "This expected rescheduling would come shortly after Germany's legalization of recreational cannabis becoming effective earlier in April.

Flora Growth Corp. Applauds Reported Historic DEA Move to Reschedule Cannabis

Acquisition capitalizes on TruHC's strategically built German cannabis platform, including: EU-GMP processing and production license GDP wholesale license for import / export EU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensaries Narcotics license with EU-GMP certified storage EU-GMP certified laboratory for instant cannabis analysis Transaction combines Flora's extensive global CPG and pharmaceutical distribution network with TruHC's deep global cannabis expertise, including an executive team with extensive experience building successful medical and recreational cannabis companies across Germany, Canada, and the United States. Germany poised to become world's largest federally legal cannabis market with expected market potential of over $10 billion with federal legalization and the critical elimination of banking, financial, capital markets, and tax constraints faced by U.S. operators.

Flora Growth Corp. Enters into Definitive Agreement to Acquire TruHC

Fort Lauderdale, Florida--(Newsfile Corp. - April 11, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, is pleased to announce it has entered an exclusive distribution agreement with Me Raw Trade Ltd. ("Me Raw") to distribute both JustCBD and Vessel branded products in Poland.

Flora Growth Enters Distribution Agreement to Expand Presence in Poland and Neighbouring Countries

Fort Lauderdale, Florida--(Newsfile Corp. - April 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, has entered into a strategic distribution agreement with IM Cannabis Corp. ("IMC") for Vessel products in Israel. Vessel is a wholly owned subsidiary of the Company and a market leading brand of vape pens and smoking accessories.

Flora Growth and IM Cannabis to Bring Vessel Products to the Israeli Market

NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC). About Flora Growth Corp. Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.

Aegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC)

Panama City, Panama--(Newsfile Corp. - April 8, 2024) - Clifford Starke (the "Acquiror") announces, pursuant to the early warning requirements of Canadian securities legislation, that he has acquired common shares (the "Common Shares") of Flora Growth Corp. ("Flora" or the "Company"), pursuant to the recently completed public offering of the Company (the "Offering"), which was completed on April 8, 2024. As a result of the Offering, the Acquiror acquired an aggregate of 526,315 Common Shares for US$1.00 million or CAD$1.36 million through YT Research Inc., an entity owned and controlled by the Acquiror.

Clifford Starke Acquires Securities of Flora Growth Corp.

Fort Lauderdale, Florida--(Newsfile Corp. - April 8, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, announced the closing of its underwritten public offering (the "Offering") of 1.7 million common shares (the "Common Shares") for aggregate gross proceeds of approximately $3.23 million, prior to deducting underwriting discounts and other offering expenses. The Company's Chief Executive Officer, Clifford Starke, purchased Common Shares in the Offering.

News for Flora Growth Corp Stock (FLGC)